CAR-T Manufacturing Cost of Goods Sold: Vein-to-Vein Economics
A 2026 analyst report on CAR-T manufacturing cost of goods sold, covering per-dose cost estimates from $16,000 vector batches to $616,500 real-world claims costs, vein-to-vein turnaround times, and decentralized manufacturing economics.